NCT00382070
Clinical Trial Information
Trial Number: NCT00382070 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Breast Cancer (Invasive)
Trial Title:
A Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared to Placebo in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed by an AI in Prolonging Disease-Free Survival in Postmenopausal Women With Hormone Receptor Positive Breast Cancer
Study ID:
NSABP-B-42
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00382070-D2 | There are two data submissions (NCT00382070-D1 and NCT00382070-D2) for PMID 30509771, the primary publication for NCT00382070 (NSABP-B-42). This dataset, NCT00382070-D2, contains toxicity data. |
| NCT00382070-D1 | There are two data submissions (NCT00382070-D1 and NCT00382070-D2) for PMID 30509771, the primary publication for NCT00382070 (NSABP-B-42). This dataset, NCT00382070-D1, contains baseline characteristic, survival, disease recurrence, and serious adverse event data. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®